NCT03860272 2025-02-06Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled
NCT06782555 2025-01-21A Study of Evofosfamide in Combination with Zalifrelimab and BalstilimabImmunoGenesisPhase 1/2 Recruiting71 enrolled